| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |